rheumatoid arthritis (RA), or psoriatic arthritis (PsA), and those with systemic lupus erythematosus (SLE) The optimal strategy for perioperative medication management remains unknown, but antirheumatic therapy is a readily modifiable risk factor for infection, whereas other risk factors for adverse outcomes, including disease activity or severity or longterm glucocorticoid (GC) use, may not be modifiable Given the increased infection risk seen in patients with IA and patients with SLE